Thumbnail for SyntheX
4 known investors
SyntheX is a drug discovery company that engineers cells using its ToRFLEx platform to run target-centric, cell-based functional selection for challenging protein targets and novel mechanisms of action. It applies synthetic biology to identify drugs that modulate protein classes historically considered undruggable, such as those altering protein levels or interactions.
AI & Machine LearningBiotechDeep Tech
Investors Β· 4
Frequently asked questions
- What does Thumbnail for SyntheX do?
- SyntheX is a drug discovery company that engineers cells using its ToRFLEx platform to run target-centric, cell-based functional selection for challenging protein targets and novel mechanisms of action. It applies synthetic biology to identify drugs that modulate protein classes historically considered undruggable, such as those altering protein levels or interactions.
- Who are Thumbnail for SyntheX's investors?
- Thumbnail for SyntheX's investors include North South Ventures, OMX Ventures, The Column Group, 8VC.

